Structural basis of antagonist selectivity in endothelin receptors.
Ontology highlight
ABSTRACT: Endothelins and their receptors, ETA and ETB, play vital roles in maintaining vascular homeostasis. Therapeutically targeting endothelin receptors, particularly through ETA antagonists, has shown efficacy in treating pulmonary arterial hypertension (PAH) and other cardiovascular- and renal-related diseases. Here we present cryo-electron microscopy structures of ETA in complex with two PAH drugs, macitentan and ambrisentan, along with zibotentan, a selective ETA antagonist, respectively. Notably, a specialized anti-ETA antibody facilitated the structural elucidation. These structures, together with the active-state structures of ET-1-bound ETA and ETB, and the agonist BQ3020-bound ETB, in comp
SUBMITTER: Hou J
PROVIDER: S-EPMC11286772 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA